Results 321 to 330 of about 88,519 (382)
Some of the next articles are maybe not open access.
Peripheral arterial occlusive disease (PAOD)
Phlebologie, 2014SummaryLeg pain on exertion is the cardinal symptom of both arterial occlusive disease. Patients with PAOD complain of cramping pain in the calf, which disappears after standing still with a straight back for a few minutes. The diagnostic and therapeutic options are discussed.
openaire +1 more source
Management of Infrapopliteal Peripheral Arterial Occlusive Disease
Current Treatment Options in Cardiovascular Medicine, 2012The management of infrapopliteal peripheral arterial occlusive disease (PAD) is challenging. For patients with asymptomatic disease or claudication, exercise and optimal medical management, including antiplatelet agents, blood pressure control, statin therapy and tight glucose control for patients with diabetes mellitus, are the mainstays of therapy ...
Warren J, Gasper +2 more
openaire +2 more sources
Haptoglobin polymorphism and peripheral arterial occlusive disease
Atherosclerosis, 1999Haptoglobin (Hp) 2-2 phenotype is a genetic risk factor in coronary atherosclerosis. In this study, haptoglobin phenotypes were determined in 141 patients with peripheral arterial occlusive disease (PAOD) and compared to a reference population (n = 1000). The relative Hp1 allele frequency was decreased among PAOD patients (0.294 vs.
J, Delanghe +4 more
openaire +2 more sources
ANTIPLATELET THERAPY IN PERIPHERAL OCCLUSIVE ARTERIAL DISEASE
ANZ Journal of Surgery, 2006Background: Antiplatelet therapy (APT) in patients with peripheral occlusive arterial disease (POAD) may reduce cardiovascular (CV) morbidity and mortality by inhibiting atherothrombosis. This article reviews the current evidence for APT in patients with stable POAD and in patients undergoing revascularization procedures for POAD.Methods: A Medline ...
Shen, Wong +2 more
openaire +2 more sources
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
Chest, 1992Abbreviations: ACD 5 absolute claudication distance; CI 5 confidence interval; INR 5 international normalized ratio; LMWH 5 low-molecular-weight heparin; MI 5 myocardial infarction; NASCET 5 North American Symptomatic Carotid Endarterectomy Trial; PGE1 5 prostaglandin E1; PGI2 5 prostaglandin I2; PTFE 5 polytetrafluoroethylene; rtPA 5 recombinant ...
G P, Clagett, R A, Graor, E W, Salzman
openaire +2 more sources
CT Angiography of Peripheral Arterial Occlusive Disease
Techniques in Vascular and Interventional Radiology, 2006Lower extremity computed tomography angiography (CTA) is an effective, noninvasive, and robust imaging modality that is being used increasingly to evaluate patients with peripheral arterial occlusive disease (PAOD). It is important for vascular and interventional radiologists, and vascular surgeons to be familiar with the strengths and limitations ...
Anne S, Chin, Geoffrey D, Rubin
openaire +2 more sources
Medical Management of Peripheral Arterial Occlusive Diseases
New England Journal of Medicine, 1953THE treatment of the patient with peripheral arterial insufficiency is increasingly successful. During the course of the disease, however, the physician is frequently called upon to resolve problem...
openaire +2 more sources
[Acute peripheral arterial occlusive disease].
Medizinische Klinik (Munich, Germany : 1983), 2008Acute lower limb ischemia is not infrequently associated with limb loss 10-30%) or death of the affected patient (15-30%). Thus, acute lower limb ischemia is an emergency. There are two categories of acute arterial occlusion: embolism (70-80%) and thrombosis (20-30%). Early diagnosis is a prerequisite for optimal management.
Romy, Schumann +2 more
openaire +1 more source
Bioabsorbable Stenting for Peripheral Arterial Occlusive Disease
Perspectives in Vascular Surgery and Endovascular Therapy, 2006Bioabsorbable stents offer an unproven but theoretically appealing means to address the deficiencies of current stent designs. Ideally, these stents would provide early postprocedural scaffolding support yet undergo a predictable process of reabsorption, thus removing the persistent stimulus for neointimal hyperplasia.
openaire +2 more sources
Determinants of Chronic Total Occlusion in Patients With Peripheral Arterial Occlusive Disease
Angiology, 2017H. Hamur +8 more
semanticscholar +1 more source